BlossomHill Therapeutics

News

Biotech financings this week include SanegeneBio's Lilly-backed $110m Series B, with Sidera, D3 Bio, BlossomHill, and Prolynx also raising new funds.

News

For the first time, children in the US as young as two with blood disorders sickle cell disease and beta thalassaemia are eligible for gene therapy.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.